Toggle navigation image image
Toggle navigation logologo
image image
  • About Inflarx
    • Leadership Team
    • Board
    • Company History
    • Vision
  • R&D
    • About Complement
    • About C5A
    • Technology
    • Pipeline
    • Clinical Development
      • Hidradenitis Suppurativa
        • Shine Study FAQ
      • ANCA-Associated Vasculitis
      • Pyoderma Gangraenosum
      • COVID-19
      • cSCC
    • Clinical Trials
    • Publications & Posters
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Share Information
    • Analyst Coverage
    • Corporate Governance
    • Annual/Extraordinary General Meetings
    • E-mail alerts
  • Career
    • Open Positions
      • Office Manager (m/w/d)
      • Controller (m/w/d)

Kofi Boaten

  • Home
  • About Inflarx
  • Leadership Team
  • Kofi Boaten
image

Kofi Boaten

Senior Director, Head of Supply Quality & Clinical Trial Supplies
 

Kofi joined InflaRx in 2018 as Head of Drug Supplies and Clinical Services.

He is a qualified pharmacist and a member of the Royal Pharmaceutical Society of Great Britain. Kofi obtained his degree in Pharmacy from the University of Bradford, West Yorkshire, Great Britain and has over 25 years’ experience in the pharmaceutical industry, starting his career initially in formulation and analytical development then moving on to and manufacture of solid dose and inhalation products and commercial transfer. He then, moved on to clinical manufacturing and supplies, vendor management and outsourcing of manufacturing, packaging, and distribution of clinical supplies. After which moved on to Quality Assurance and Regulatory Compliance, eventually becoming an IMP QP and site QA lead (manager) supporting formulation (drug) development teams across three R&D sites working across multiple dosage forms (solid dose (tablets & capsules), liquids & suspensions, inhalation (powder & aerosol), biologics and biosimilars.


Throughout the course of his career Kofi has supported 7 compounds (2 solid dosage forms, 2 inhalation dosage forms 3 biosimilars) he has supported through discovery, development through to commercialisation.


Kofi's passion is compliance and operational excellence, keeping abreast of the changing pharmaceutical regulatory landscape and ensuring InflaRx are in a good position to take advantage of opportunities and avoid pitfalls / unnecessary hurdles. He is a member of the Research Quality Assurance (RQA, formally BARQA - British Association of Research Quality Assurance) and the International Society for Pharmaceutical Engineering (ISPE) Patient Centric Logistic & Quality Sub-teams.

Quick Links
  • Impressum
  • Privacy
  • Technology
  • News
  • Career
  • Disclaimer
  • Contact
  • Newsletter
  • Member area
Contact Jena

InflaRx N.V. / InflaRx GmbH
Winzerlaer Str. 2
07745 Jena

+49 3641 508 180

info@inflarx.de

InflaRx on Linkedin

Contact Munich

InflaRx N.V. / InflaRx GmbH
Fraunhoferstraße 22
82152 Martinsried

+49 89 414 189 78 00

info@inflarx.de

Contact Ann Arbor

InflaRx Pharmaceuticals Inc.
600 S. Wagner Rd.
Ann Arbor, MI 48103

info@inflarx.de

© Copyright 2017 All Rights Reserved.
  • Developed by Ementals